Page 81 - GTM-1-2
P. 81

Global Translational Medicine                                               Succinate metabolism in CVD



            accumulation and inducing cardiomyocyte proliferation   through the phosphatidylinositol 3-kinase/protein kinase
            and heart regeneration . SDH is the most crucial enzyme   B (PI3K/Akt) signaling pathway . In a previous study, a
                                                                                         [63]
                              [56]
            for succinate accumulation and oxidation to produce ROS   patient who presented with congestive heart failure was
            during  ischemia-reperfusion.  Dimethyl  malonate  has  a   found deficient in succinate dehydrogenase, which caused
            protective effect on  ischemia-reperfusion  injury  in pre-  succinate to accumulate extracellularly . Succinate
                                                                                                  [64]
            ischemia or ischemia . In a porcine ischemia-reperfusion   activates the cardiomyocyte PKA pathway, regulates
                            [24]
                                                                             2+
            model, coronary administration of dimethyl malonate was   cardiomyocyte Ca  transients through SUCNR1, reduces
            found to be cardioprotective . In addition to its role in   ventricular cardiomyocyte viability, increases caspase-3
                                   [57]
                                                                                                       [65]
            myocardial infarction, SDH inhibitors can also be used in   activity, and leads to cardiomyocyte apoptosis . The
                                                                 2+
            predictable ischemic  processes,  such  as  ischemic  stroke,   Ca  transient is an important indicator of myocardial
            kidney disease, and organ transplantation. Dimethyl   hypertrophy . These results suggest that succinate
                                                                         [66]
            malonate has been shown to reduce brain damage after   promotes cardiomyocyte apoptosis and Ca  transients,
                                                                                                   2+
                             [58]
            cardiac arrest in rats . Malonic acid may emerge as a   resulting in myocardial hypertrophy and heart failure.
            potential treatment for reducing injuries during organ   3.6. Succinate and metabolic cardiomyopathy
            transplantation.
                                                               Metabolic cardiomyopathy is a type of cardiomyopathy
              Isolated organs are in a state of hypoxia, which leads
            to the accumulation of succinate in the organs and   caused by metabolic disorders, primarily glucose, and lipid
                                                               metabolism disorders, some of which include heart failure
            oxidation after reperfusion, resulting in tissue injury and   with preserved ejection fraction, diabetic cardiomyopathy,
            inflammation. The cold storage solution can slow down the   and Takotsubo syndrome. [67,68]  Obesity, body fat, and
            metabolism and the production of succinate, thus reducing   body mass index are significant risk factors for these
            the production of mitochondrial ROS during reperfusion   cardiomyopathies, and succinate may this condition.
            and in reperfusion injury . In a recent study related to
                                 [59]
            organ transplantation, a new storage method was designed   Obesity  may  lead  to  metabolic  disorders  of  adipose
            to preserve the heart for transplantation. Hypothermia   tissue, leading to macrophage infiltration and chronic
            oxygenation was used to raise the level of adenosine   inflammation. Succinate-SUCNR1 mediates adipose
            triphosphate/adenosine diphosphate (ATP/ADP) in    tissue macrophage infiltration and glucose intolerance in
                                                                     [37]
            the perfusion tissue, which reduced the level of cardiac   obesity . The knockout of SUCNR1 results in a significant
                                                                                                           [37]
            succinate and cell injury, thus achieving a protective effect   reduction in macrophage infiltration in adipose tissues .
            on the heart . A  large amount of succinate tends to   In addition to worsening obesity, inflammation and glucose
                       [60]
            accumulate in ischemic tissue, but following reperfusion,   intolerance may occur as a result of macrophage-specific
                                                                                  [69]
            succinate is rapidly oxidized by SDH, and excess ROS are   deficiency of SUCNR1 . The elevated plasma level of
            produced through mitochondrial respiratory complex I,   succinate is related to metabolic abnormalities. In obese
            resulting in calcium imbalance and ATP depletion, which   people, the level of succinate in the circulation increases,
            lead to further damage and myocardial cell death .  while the expression of SUCNR1 in adipose tissue-resident
                                                   [24]
                                                                                  [70]
                                                               macrophages  decreases .  The  thermogenic  activity  of
            3.5. Succinate and myocardial hypertrophy and      brown adipose tissue (BAT) plays a significant role in obesity.
            heart failure                                      Uncoupling protein 1 (UCP1), which is a key thermogenic
            Cardiac overload is the primary cause of heart failure.   protein expressed in brown and beige adipocytes, regulates
            Myocardial  hypertrophy  is  the  main  compensatory   the removal of succinate from the circulation of brown
            mechanism with an increase in cardiac afterload. The   and beige fat. High levels of succinate are rapidly absorbed
            apoptosis of cardiomyocytes has a significant role in the   by adipocyte mitochondria, producing ROS through
                                                               SDH-mediated succinate oxidation, driving UCP1-
            transition from myocardial hypertrophy to heart failure .   dependent thermogenic respiration, and then regulating
                                                        [61]
            Pathological myocardial hypertrophy is a major risk   liver inflammation and glucose intolerance under obesity
            factor for various CVDs and sudden death, but there is no   conditions [71,72] . In a cold exposure mouse model, succinate
            effective treatment strategy at present.
                                                               accumulated in brown adipocytes, reduced HFD-induced
              Succinate triggers ERK1/2 phosphorylation, Ca /  obesity, and enhanced thermogenesis in BAT through
                                                        2+
            calmodulin-dependent protein kinase II delta (CaMKIIδ)   non-adrenergic signaling pathways . Therefore, succinate
                                                                                           [71]
            expression, and intracellular histone deacetylase 5 (HDAC5   can be regarded as an activator of BAT thermogenesis.
            translocation) through SUCNR1, leading to cardiomyocyte   Interestingly, the exogenous supplementation of succinate
                      [62]
            hypertrophy . Succinate-SUCNR1 is involved in right   to pregnant and lactating female mice was found to
            ventricular  hypertrophy  induced  by  pressure  overload   promote the development of brown fat in newborn mice

            Volume 1 Issue 2 (2022)                         6                      https://doi.org/10.36922/gtm.v1i2.160
   76   77   78   79   80   81   82   83   84   85   86